Medical Devices — Regulation charge
Business Segments · Regulation chargeJohnson & Johnson Medical Devices — Regulation charge remained flat by 0.0% to $50.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $75.00M to $50.00M. Over 3 years (FY 2021 to FY 2024), Medical Devices — Regulation charge shows an upward trend with a 26.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase signals heightened regulatory risk or legal exposure, which can negatively impact segment margins and operational stability.
Detailed definition
This metric captures non-recurring costs or provisions related to regulatory compliance, legal settlements, or changes i...
Peer comparison
Comparable to 'Legal and Regulatory Charges' or 'Litigation Provisions' reported by peers in the highly regulated medical device industry.
jnj_segment_medtech_regulation_chargeHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $100.00M | $300.00M | $300.00M | $200.00M |
| YoY Change | — | +200.0% | +0.0% | -33.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — regulation charge?
- Johnson & Johnson (JNJ) reported medical devices — regulation charge of $50.00M in Q4 2024.
- How has Johnson & Johnson's medical devices — regulation charge changed year-over-year?
- Johnson & Johnson's medical devices — regulation charge decreased by 33.3% year-over-year, from $75.00M to $50.00M.
- What is the long-term trend for Johnson & Johnson's medical devices — regulation charge?
- Over 3 years (2021 to 2024), Johnson & Johnson's medical devices — regulation charge has grown at a 26.0% compound annual growth rate (CAGR), from $100.00M to $200.00M.
- What does medical devices — regulation charge mean?
- Costs incurred due to regulatory compliance issues, legal settlements, or government-mandated operational changes.